On the 30th of September, Nikko Asset Management Americas sold 1.7 million NanoString Technologies, Inc. (NSTG) shares for $44 million at an average price of $26.38 per share.
Shares of NanoString Technologies, Inc. are down -11.01% since the transaction.
Nikko Asset Management Americas's holding in NanoString Technologies, Inc. decreased to about 1.9 million shares with the transaction.
Nikko Asset Management Americas first bought NanoString Technologies, Inc. stock in the third quarter of 2018.
Nikko Asset Management Americas also owns Illumina (NASDAQ:), CRISPR Therapeutics AG (CRSP), Editas Medicine Inc (NASDAQ:) and Intellia Therapeutics Inc (NASDAQ:).
NanoString Technologies, Inc. is its number six position by number of shares and market value among biotechnology & life sciences stocks.
Other investors who also reduced their NanoString Technologies, Inc. shares include TimesSquare Capital Management, Polar Capital, and Victory Capital Management.
In contrast, California State Teachers Retirement System added to NSTG shares, while Millennium Management established new holdings in NanoString Technologies, Inc.
Nikko Asset Management Americas also reduced their share in Seres Therapeutics, Inc. (NASDAQ:).
The total value of the shares sold is estimated at around $11 million.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.